Privia Health Group, Inc.
NASDAQ:PRVA · NASDAQ Global Select
+$0.15 today
Vol 1.68M · Avg 0.95M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+9.53%
Period High
$26.40
Period Low
$18.86
Latest
$23.67
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Travere Therapeutics, Inc.
NASDAQ:TVTX
$5.06B
LivaNova PLC
NASDAQ:LIVN
$4.36B
Envista Holdings Corp
NYSE:NVST
$4.17B
ICU Medical, Inc.
NASDAQ:ICUI
$3.48B
Arcutis Biotherapeutics, Inc.
NASDAQ:ARQT
$3.23B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.87B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.54B
Premier, Inc.
PINC
$2.34B
Prestige Consumer Healthcare Inc.
NYSE:PBH
$2.20B
Alphatec Holdings, Inc.
NASDAQ:ATEC
$1.32B
What is the latest PRVA filing?
The latest filing shown is 4 dated May 22, 2026.
How many recent filings does PRVA have?
Intrinsic Alpha currently shows 20 recent filings for PRVA.
Explore More
Continue the stock analysis
Jump to another research area for this company.